Filing Details
- Accession Number:
- 0001193125-20-024713
- Form Type:
- 13G Filing
- Publication Date:
- 2020-02-05 06:13:02
- Filed By:
- Synergy Life Science Partners L P
- Company:
- Inspire Medical Systems Inc. (NYSE:INSP)
- Filing Date:
- 2020-02-05
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Synergy Life Science Partners | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Synergy Venture Partners | 0 | 0 | 0 | 0 | 0 | 0.0% |
| Richard S. Stack | 35,459 | 0 | 35,459 | 0 | 35,459 | 0.0% |
| William N. Starling, Jr | 22,874 | 0 | 22,874 | 0 | 22,874 | 0.0% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b),
(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)
(Amendment No. 1)*
Inspire Medical Systems, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
457730109
(CUSIP Number)
December 31, 2019
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP NO. 457730109 | 13 G |
| 1 | NAMES OF REPORTING PERSONS.
Synergy Life Science Partners, LP | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ (1)
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
0 shares | ||||
| 6 | SHARED VOTING POWER
0 shares | |||||
| 7 | SOLE DISPOSITIVE POWER
0 shares | |||||
| 8 | SHARED DISPOSITIVE POWER
0 shares | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% | |||||
| 12 | TYPE OF REPORTING PERSON*
PN | |||||
| (1) | This Schedule 13G is filed by Synergy Life Science Partners, LP, a Delaware limited partnership (SLSP), Synergy Venture Partners, LLC, a Delaware limited liability company (SVP), Richard S. Stack (Stack) and William N. Starling, Jr. (Starling and together with SLSP, SVP, and Stack, collectively, the Reporting Persons). The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019. |
| CUSIP NO. 457730109 | 13 G |
| 1 | NAMES OF REPORTING PERSONS.
Synergy Venture Partners, LLC | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ (1)
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF
ORGANIZATION
Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
0 shares | ||||
| 6 | SHARED VOTING POWER
0 shares | |||||
| 7 | SOLE DISPOSITIVE POWER
0 shares | |||||
| 8 | SHARED DISPOSITIVE POWER
0 shares | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 shares | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% | |||||
| 12 | TYPE OF REPORTING PERSON*
OO | |||||
| (1) | This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019. |
| CUSIP NO. 457730109 | 13 G |
| 1 | NAMES OF REPORTING PERSONS.
Richard S. Stack | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ (1)
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF
ORGANIZATION
United States of America | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
35,459 shares | ||||
| 6 | SHARED VOTING POWER
0 shares | |||||
| 7 | SOLE DISPOSITIVE POWER
35,459 shares | |||||
| 8 | SHARED DISPOSITIVE POWER
0 shares | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
35,459 shares | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% | |||||
| 12 | TYPE OF REPORTING PERSON*
IN | |||||
| (1) | This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019. |
| CUSIP NO. 457730109 | 13 G |
| 1 | NAMES OF REPORTING PERSONS.
William N. Starling, Jr. | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☒ (1)
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF
ORGANIZATION
United States of America | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
22,874 shares | ||||
| 6 | SHARED VOTING POWER
0 shares | |||||
| 7 | SOLE DISPOSITIVE POWER
22,874 shares | |||||
| 8 | SHARED DISPOSITIVE POWER
0 shares | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
22,874 shares | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.0% | |||||
| 12 | TYPE OF REPORTING PERSON*
IN | |||||
| (1) | This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a group for purposes of this Schedule 13G. The information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019. |
Introductory Note: This Statement on Schedule 13G (this Statement) is filed on behalf of the Reporting Persons, in respect of shares of Common Stock, par value $0.001 per share (Common Stock), of Inspire Medical Systems, Inc. (the Issuer).
| Item 1 |
| (a) | Name of Issuer: | Inspire Medical Systems, Inc. | ||
| Address of Issuers Principal Executive Offices: | 5500 Wayzata Blvd., Suite 1600 | |||
| Golden Valley, MN 55416 | ||||
| Item 2 |
| (a) | Name of Person(s) Filing: | |
| Synergy Life Science Partners, LP (SLSP) Synergy Venture Partners, LLC (SVP) Richard S. Stack (Stack) William N. Starling, Jr. (Starling) | ||
| (b) | Address of Principal Business Office: | c/o Synergy Life Science Partners | ||
| 4020 Stirrup Creek Drive, Suite 115 | ||||
| Durham, NC 27703 |
| (c) | Citizenship: | |||||||
| Entities: | SLSP | - | Delaware | |||||
| SVP | - | Delaware | ||||||
| Individuals: | Stack | - | United States of America | |||||
| Starling | - | United States of America | ||||||
| (d) | Title of Class of Securities: | Common Stock | ||||||
| (e) | CUSIP Number: | 457730109 | ||||||
| Item 3 | Not applicable. |
| Item 4 | Ownership. |
The following information with respect to the ownership of the Common Stock by the Reporting Persons filing this statement on Schedule 13G is provided as of December 31, 2019:
| Filing Person | Shares of Common Stock | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Beneficial Ownership | Percentage of Class | |||||||||||||||||||||
| Synergy Life Science Partners, LP | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | % | ||||||||||||||||||||
| Synergy Venture Partners, LLC | 0 | 0 | 0 | 0 | 0 | 0 | 0.0 | % | ||||||||||||||||||||
| William N. Starling, Jr. | 22,874 | 22,874 | 0 | 22,874 | 0 | 22,874 | 0.0 | % | ||||||||||||||||||||
| Richard S. Stack | 35,459 | 35,459 | 0 | 35,459 | 0 | 35,459 | 0.0 | % | ||||||||||||||||||||
| Item 5 | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒
| Item 6 | Ownership of More Than Five Percent on Behalf of Another Person. |
Not applicable.
| Item 7 | Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company. |
Not applicable.
| Item 8 | Identification and Classification of Members of the Group. |
Not applicable.
| Item 9 | Notice of Dissolution of Group. |
Not applicable.
| Item 10 | Certification. |
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 5, 2020
| SYNERGY LIFE SCIENCE PARTNERS, LP | ||
| By: Synergy Venture Partners, LLC | ||
| Its: General Partner | ||
| By: | /s/ William N. Starling, Jr. | |
| Name: William N. Starling, Jr. | ||
| Title: Manager | ||
| SYNERGY VENTURE PARTNERS, LLC | ||
| By: | /s/ William N. Starling, Jr. | |
| Name: William N. Starling, Jr. | ||
| Title: Manager | ||
| /s/ William N. Starling, Jr. | ||
| William N. Starling, Jr. | ||
| /s/ Richard S. Stack | ||
| Richard S. Stack | ||
Exhibit(s):
A - Joint Filing Statement